Literature DB >> 32023077

The Use of Benralizumab in the Treatment of Near-Fatal Asthma: A New Approach.

Sanjay Ramakrishnan1, James R Camp1, Bavithra Vijayakumar2, Frances M Hardinge2, Matilda L Downs1,3, Richard E K Russell1,3, Ian D Pavord1,3, Mona Bafadhel1.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32023077      PMCID： PMC7258629          DOI： 10.1164/rccm.202001-0093LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  6 in total

1.  Changes in circulating leukocytes following the administration of adrenal cortex extract (ACE) and adrenocorticotropic hormone (ACTH) in infectious mononucleosis and chronic lymphatic leukemia.

Authors:  R H SAUNDERS; E ADAMS
Journal:  Blood       Date:  1950-08       Impact factor: 22.113

2.  Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial.

Authors:  Eugene R Bleecker; J Mark FitzGerald; Pascal Chanez; Alberto Papi; Steven F Weinstein; Peter Barker; Stephanie Sproule; Geoffrey Gilmartin; Magnus Aurivillius; Viktoria Werkström; Mitchell Goldman
Journal:  Lancet       Date:  2016-09-05       Impact factor: 79.321

3.  Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy.

Authors:  Sarah Mrejen; Chandrakumar Balaratnasingam; Talia R Kaden; Alexander Bottini; Kunal Dansingani; Kavita V Bhavsar; Nicolas A Yannuzzi; Samir Patel; Kevin C Chen; Suqin Yu; Guillaume Stoffels; Richard F Spaide; K Bailey Freund; Lawrence A Yannuzzi
Journal:  Ophthalmology       Date:  2019-01-17       Impact factor: 12.079

4.  A randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthma.

Authors:  Richard M Nowak; Joseph M Parker; Robert A Silverman; Brian H Rowe; Howard Smithline; Faiz Khan; Jon P Fiening; Keunpyo Kim; Nestor A Molfino
Journal:  Am J Emerg Med       Date:  2014-10-05       Impact factor: 2.469

5.  Central serous chorioretinopathy secondary to corticosteroids in patients with atopic disease.

Authors:  Peter A Ricketti; David W Unkle; Dennis J Cleri; Jonathan L Prenner; Michael Coluccielo; Anthony J Ricketti
Journal:  Allergy Asthma Proc       Date:  2015 Mar-Apr       Impact factor: 2.587

6.  Risk factors for central serous chorioretinopathy: a case-control study.

Authors:  Robert Haimovici; Sean Koh; David R Gagnon; Todd Lehrfeld; Sarah Wellik
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079
  6 in total
  3 in total

Review 1.  Update in Adult Asthma 2020.

Authors:  Andrew J Halayko; Christopher D Pascoe; Jessica D Gereige; Michael C Peters; Robyn T Cohen; Prescott G Woodruff
Journal:  Am J Respir Crit Care Med       Date:  2021-08-15       Impact factor: 21.405

2.  Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma.

Authors:  Angela M Moran; Sanjay Ramakrishnan; Catherine A Borg; Clare M Connolly; Simon Couillard; Christine M Mwasuku; Ian D Pavord; Timothy S C Hinks; Lauri Lehtimӓki
Journal:  Am J Respir Crit Care Med       Date:  2020-11-01       Impact factor: 21.405

3.  Reply to: Challenging the paradigm.

Authors:  Andrew Bush; Ian D Pavord
Journal:  Breathe (Sheff)       Date:  2021-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.